The effect of a liberal red-cell transfusion strategy as compared with a restrictive strategy in patients during the critical care period after an aneurysmal subarachnoid hemorrhage is unclear. We ...
A Prescription Drug User Fee Act target date of April 23, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...
Grace Therapeutics (NASDAQ:GRCE) announced that its late-stage trial of GTx-104 met its primary endpoint and provides ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback